Tag Archives: MYND Life Sciences

Vancouver, British Columbia–(Newsfile Corp. – April 9, 2025) – Mynd Life Sciences Inc. (CNSX: MYND) (“Mynd” or the “Company”) announced on March 3, 2025 the Company was granted a management cease trade order (MCTO) under the National Policy 12-203 of the Canadian Securities Administrators (“NP 12-203”) imposed against certain insiders …

Vancouver, British Columbia–(Newsfile Corp. – March 24, 2025) – MYND Life Sciences Inc. (CSE: MYND) (“MYND” or the “Company”) announced on March 3, 2025, the Company was granted a management cease trade order (MCTO) under the National Policy 12-203 of the Canadian Securities Administrators (“NP 12-203”) imposed against certain insiders …

Vancouver, British Columbia–(Newsfile Corp. – March 3, 2025) – Mynd Life Sciences Inc. (CNSX: MYND) (“Mynd” or the “Company”) announces that it has been advised by its external auditors (the “Auditors”) that they will not be in a position to complete their work on the Company’s annual consolidated financial statements …

Vancouver, British Columbia–(Newsfile Corp. – February 11, 2025) – MYND Life Sciences Inc. (CSE: MYND) (OTC Pink: MYNDF) (“MYND” or the “Company”) a clinical-stage life sciences company committed to the development and commercialization of drug therapies and diagnostics to improve the monitoring and treatment of depression, today announced that it …